Consistent with these findings, immunohistochemical analysis of tumor samples revealed a notable decrease in the expression levels of two proliferation markers, Ki67 and PCNA, in T4O-treated mice compared to control animals (Fig. 5D). Here, MKI67 is linked to neoplasm.